Monday, October 31, 2022
sus/email
¬¬⧇¬¬ Milanar90026 | 𝖢𝖺𝗆𝗉𝗅𝖾𝗃𝖾𝗎𝗇𝖾𝗌𝗎𝗂𝗍.𝗈𝗋𝗀 ¬¬⧇¬¬
To:
milanar90026@yahoo.com
,
milanar90026@yahoo.com
Mon, Oct 31 at 8:35 AM
~~Camplejeunesuit.org~~
Hey Milanar90026,
YOU ARE ENTITLED TO SIGNIFICANT COMPENSATION!!
According To Camp Lejeune Justice Act passes U.S. Senate as part of PACT Act as of August 10th, 2022*
Potential Claim Has Been SETTLED on 1O/3O/2O22 and Compensation Has Been Approved!
__Please Claim_Your_Compensation Today__
__Confirm your info below__
Username: Milanar90026
Email: milanar90026@yahoo.com
Reference ID: Camp418838
Claim Settlement: In Full [Amount Disclosed Below]
Today is the LAST DAY to Claim Your Compensation.
CLICK HERE
¬¬⧇¬¬ Milanar90026 | 𝖢𝖺𝗆𝗉𝗅𝖾𝗃𝖾𝗎𝗇𝖾𝗌𝗎𝗂𝗍.𝗈𝗋𝗀 ¬¬⧇¬¬
To:
milanar90026@yahoo.com
,
milanar90026@yahoo.com
Mon, Oct 31 at 8:35 AM
~~Camplejeunesuit.org~~
Hey Milanar90026,
YOU ARE ENTITLED TO SIGNIFICANT COMPENSATION!!
According To Camp Lejeune Justice Act passes U.S. Senate as part of PACT Act as of August 10th, 2022*
Potential Claim Has Been SETTLED on 1O/3O/2O22 and Compensation Has Been Approved!
__Please Claim_Your_Compensation Today__
__Confirm your info below__
Username: Milanar90026
Email: milanar90026@yahoo.com
Reference ID: Camp418838
Claim Settlement: In Full [Amount Disclosed Below]
Today is the LAST DAY to Claim Your Compensation.
CLICK HERE
.
¬¬⧇¬¬ Milanar90026 | 𝖢𝖺𝗆𝗉𝗅𝖾𝗃𝖾𝗎𝗇𝖾𝗌𝗎𝗂𝗍.𝗈𝗋𝗀 ¬¬⧇¬¬
To:
milanar90026@yahoo.com
,
milanar90026@yahoo.com
Mon, Oct 31 at 8:35 AM
~~Camplejeunesuit.org~~
Hey Milanar90026,
YOU ARE ENTITLED TO SIGNIFICANT COMPENSATION!!
According To Camp Lejeune Justice Act passes U.S. Senate as part of PACT Act as of August 10th, 2022*
Potential Claim Has Been SETTLED on 1O/3O/2O22 and Compensation Has Been Approved!
__Please Claim_Your_Compensation Today__
__Confirm your info below__
Username: Milanar90026
Email: milanar90026@yahoo.com
Reference ID: Camp418838
Claim Settlement: In Full [Amount Disclosed Below]
Today is the LAST DAY to Claim Your Compensation.
CLICK HERE
.
.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment